UnitedHealth Stock (UNH) Plummets 37% YTD Amid Regulatory Scrutiny, Technicals Signal Buy Opportunity

UnitedHealth Group's stock has cratered 37% year-to-date, ranking among the S&P 500's worst performers in 2025. The health insurer faces a perfect storm of earnings shortfalls, Medicare billing investigations, and leadership turmoil that eroded market confidence.

Technical indicators now flash bullish signals. The stock trades at $315.39—well above its 50-day EMA of $298.16—while its 14.32 ROC score confirms upward momentum. Williams %R analysis further supports the buying thesis, suggesting the selloff may have overshot fundamentals.

Market technicians view this as a classic contrarian play. When regulatory clouds lift, historically oversold healthcare stocks like UNH often see violent rebounds. The current technical setup mirrors previous bottoms in managed care stocks during past policy crises.